September 18, 2025 · Form 4 insider transaction
Oki Mark K bought 168,000 shares of Oncothyreon Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II.